Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
of New Mexico Health Sciences Center is looking for a Research Scientist 1. Dr. Singh’s lab focuses on decoding the epigenetic basis of ocular & metastatic cancers, dry age-related macular degeneration
-
, chemistry, biotechnology, medicine, pharmacy, biomedical sciences) Minimum 2 ISI publications in fields related to the project: genetics, epigenetics, inflammation, metabolic pathology, autoinflammatory
-
working time of 1,627.50 hours (37.5 hours/week). • EPIF salary. • Research Group: Cancer Epigenetics. Where to apply E-mail seleccio@recercasantpau.cat Requirements Research FieldOtherEducation LevelPhD
-
January 2026 (6pm CET). The deadline for referees to submit reference letters is 14 January 2026 (6pm CET). Please check our website https://www.molgen.mpg.de/IMPRS/application for more details. Tuition
-
biologists and bioinformaticians and will be expected to draw on the group’s expertise in breast cancer research, cell and molecular biology, epigenetics, advanced microscopy, high-throughput genomics and
-
CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences | Austria | 2 months ago
research groups for 3 to 6 years, addressing ambitious research questions in areas such as cancer, immunology, chemical biology, epigenetics, metabolism, genomic medicine, and ageing research. Research
-
, and high throughput sequencing among other assays to study the underlying causes and developmental course of autoimmune diseases from a lncRNA and epigenetic gene regulation perspective. This research
-
animal models, including behavioral assessments, to investigate acute and chronic pain particularly in aging utilizing molecular biology, biochemistry, and epigenetic techniques. Contribute to training and
-
combining research in cell biology, genetics, epigenetics, immunology, soft matter physics, organic chemistry, and medicinal chemistry. It brings together more than 3,800 researchers, doctors, clinicians
-
in tumor microenvironment of prostate and breast cancer. The group also studies various epigenetic processes (histone phosphorylation, methylation and acetylation) that drive these diseases and their